サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1226953

北米の水産養殖用ワクチン市場の2028年までの予測-地域別分析-ワクチンタイプ別、種別、投与経路別

North America Aquaculture Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type of Vaccine, Species, and Route of Administration
出版日: | 発行: The Insight Partners | ページ情報: 英文 111 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
北米の水産養殖用ワクチン市場の2028年までの予測-地域別分析-ワクチンタイプ別、種別、投与経路別
出版日: 2023年02月20日
発行: The Insight Partners
ページ情報: 英文 111 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米の水産養殖用ワクチン市場は、2022年の1億2,536万米ドルから2028年には2億5,632万米ドルに成長すると予測されます。2022年から2028年までのCAGRは12.7%で成長すると推定されています。

水産養殖産業の成長が北米の水産養殖用ワクチン市場を牽引する

米国食糧農業機関が2022年に発表した「The State of World Fisheries and Aquaculture」という報告書のデータによると、藻類を除く水生食品の世界消費量は、約60年前の消費量の5倍以上に増加しています。全世界の水生食品消費量は、1961年の2,800万トンから2019年には～1億5,800万トンに増加しました。人口増加率1.6%に対し、消費量は1961年から年平均3.0%で増加しました。一人当たりの消費量は、供給量の増加、消費者の嗜好の変化、所得の増加により増加しています。2019年、国連食糧農業機関は227カ国の水産物一人当たりの消費量を推定しました。人口については、世界平均より少ない消費量の国が2019年の世界人口の54 %を占めました。水生動物の消費量の増加は、水産養殖産業の成長を促進しています。水産養殖用ワクチンは、感染の可能性を下げ、製品の収量を増加させます。したがって、水産養殖産業の成長は、水産養殖用ワクチン市場の成長を後押ししています。

北米の水産養殖用ワクチン市場の概要

北米の水産養殖用ワクチン市場は、米国、カナダ、メキシコに区分されます。この地域の市場成長は、水産養殖産業の成長と水産動物由来の食品に対する需要の急増に起因しています。米国の水産養殖用ワクチン市場は、北米で大きなシェアを占めています。この市場の成長は、養殖生産の増加、養殖セクターにおける感染症の高い流行、新しい養殖ワクチンの開発・発売の増加によるものです。The OECD Review of Fisheries 2020によると、2018年、米国は520万トンの魚を生産し、70億6,350万米ドルとなっています。83%が漁業からで、この金額の17%が養殖からです。2008年から2018年の間に、生産量は7％増加し、その価値は29％上昇しました。さらに、2020年7月、ゾエティスは、魚用ワクチンの開発・商業化、水産養殖用ワクチン接種・診断のサービスを提供するファーマ事業の戦略的追加として、Benchmark Holdings, PLCからFish Vet Groupを買収しました。Fish Vet Groupの追加により、ファーマックのリファレンスラボであるPharmaq Analytiqが主要な養殖市場の養殖業者に提供できる診断の専門知識と環境検査を含む検査サービスの地理的範囲が拡大し、改善されました。このように、米国の養殖産業におけるさまざまな市場関係者による開拓は、前述の要因とともに、米国の水産養殖用ワクチン市場を後押しすることになるでしょう。

北米の水産養殖用ワクチン市場の収益と2028年までの予測（金額）

北米の水産養殖用ワクチン市場のセグメンテーション

北米の水産養殖用ワクチン市場は、ワクチンタイプ、種、投与経路、国ごとに区分されています。

北米の水産養殖用ワクチン市場は、ワクチンタイプに基づき、生ワクチンと不活化ワクチン、その他のワクチンに分類されます。2022年には、不活化ワクチン分野が最大の市場シェアを占めています。

種別では、北米の水産養殖用ワクチン市場は、ティラピア、マス、サケ、エビ、その他に分けられます。2022年にはサーモンセグメントが最大のシェアを占めています。

投与経路に基づき、北米の水産養殖用ワクチン市場は、注射ワクチン、浸漬ワクチン、経口ワクチンに区分されます。2022年には、注射ワクチン分野が市場で最大のシェアを占めました。

国別に見ると、北米の水産養殖用ワクチン市場は、米国、カナダ、メキシコに区分されます。2022年の水産養殖用ワクチン市場シェアは米国が独占しました。

AquaTactics Fish Health、HIPRA SA、Merck &Co Inc.、Zoetis Inc.、Phibro Animal Health Corp、Elanco Animal Health Inc.は、北米の水産養殖用ワクチン市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 北米養殖ワクチン市場- 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 北米の水産養殖用ワクチン市場- 市場情勢

  • 北米のPEST分析
  • 専門家の見解

第5章 北米の水産養殖用ワクチン市場-主要市場力学

  • 市場促進要因
    • 成長する水産養殖産業
    • 水生動物由来食品への需要の高まり
  • 市場抑制要因
    • ワクチン認可のための厳しい規制政策とワクチンコストの高さ
  • 今後の動向
    • 新規ワクチンの開発
  • 影響度分析

第6章 水産養殖用ワクチン市場-北米の分析

  • 北米の水産養殖用ワクチン市場の収益予測と分析

第7章 北米の水産養殖用ワクチン市場-収益と2028年までの予測：ワクチンタイプ別

  • 北米の水産養殖用ワクチン市場の売上高シェア：ワクチンの種類別2021年・2028年（%）
  • 生ワクチンのみ
  • 不活化ワクチン
  • その他のワクチン

第8章 北米の水産養殖用ワクチン市場の分析と2028年までの予測：種別

  • 北米の水産養殖用ワクチン市場：種別2021年・2028年（%）
  • ティラピア
  • トラウト
  • サーモン
  • シュリンプ
  • その他

第9章 北米の水産養殖用ワクチン市場収益と2028年までの予測：投与経路別

  • 北米の水産養殖用ワクチン市場2021年・2028年売上高シェア（%）：投与経路別
  • 注射用ワクチン
  • 浸漬型ワクチン
  • 経口ワクチン

第10章 北米の水産養殖用ワクチン市場- 収益と2028年までの予測- 国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第11章 水産養殖用ワクチン市場- 業界情勢

  • 水産養殖用ワクチン市場の成長戦略
  • 有機的な成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • AquaTactics Fish Health
  • HIPRA SA
  • Merck & Co Inc
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Elanco Animal Health Inc

第13章 付録

図表

List Of Tables

  • Table 1. US Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. US Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. US Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Canada Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Canada Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Canada Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Mexico Aquaculture Vaccines Market, by Type of Vaccine - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Mexico Aquaculture Vaccines Market, by Species - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Mexico Aquaculture Vaccines Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Recent Organic Growth Strategies in Aquaculture Vaccines Market
  • Table 11. Recent Inorganic Growth Strategies in the Aquaculture Vaccines Market
  • Table 12. Glossary of Terms

List Of Figures

  • Figure 1. North America Aquaculture Vaccines Market Segmentation
  • Figure 2. North America Aquaculture Vaccines Market, by Country
  • Figure 3. North America Aquaculture Vaccines Market Overview
  • Figure 4. Inactivated Vaccine Segment Held Largest Share of Type Segment in North America Aquaculture Vaccines Market
  • Figure 5. Canada is Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. North America Aquaculture Vaccines Market Impact Analysis of Drivers and Restraints
  • Figure 9. North America Aquaculture Vaccines Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 10. North America Aquaculture Vaccines Market Revenue Share, by Type of Vaccine 2021 & 2028 (%)
  • Figure 11. Live Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Inactivated Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Other Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. North America Aquaculture Vaccines Market, by Species 2021 & 2028 (%)
  • Figure 15. Tilapia: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Trout: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Salmon: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Shrimps: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Others: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. North America Aquaculture Vaccines Market Revenue Share, by Route of Administration 2021 & 2028 (%)
  • Figure 21. Injection Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Immersions Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Oral Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. North America: Aquaculture Vaccines Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 25. North America: Aquaculture Vaccines Market, by Country, 2021 & 2028 (%)
  • Figure 26. US: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Canada: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Mexico: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Growth Strategies in Aquaculture Vaccines Market
目次
Product Code: BMIRE00028128

The North America aquaculture vaccines market is expected to grow from US$ 125.36 million in 2022 to US$ 256.32 million by 2028. It is estimated to grow at a CAGR of 12.7% from 2022 to 2028.

Growing Aquaculture Industry is Driving the North America Aquaculture Vaccines Market

According to the data in a report titled "The State of World Fisheries and Aquaculture" published by the Food and Agriculture Organization of the United Nations in 2022, global consumption of aquatic foods, excluding algae, has increased by more than five times the quantity consumed nearly 60 years ago. Aquatic food consumption across the world increased from 28 million tonnes in 1961 to ~158 million tonnes in 2019. The consumption increased at an average annual rate of 3.0 % from 1961, compared with a population growth rate of 1.6 %. Per capita consumption is rising due to increasing supplies, changing consumer preferences, and growing income. In 2019, the Food and Agriculture Organization of the United Nations estimated the per capita consumption of aquatic foods for 227 countries. Regarding population, the countries consuming less than the world average accounted for 54 % of the world population in 2019. The rising consumption of aquatic animals is expediting the growth of the aquaculture industry. Aquaculture vaccines lower the chance of infection and increase the yield of products. Therefore, the growing aquaculture industry fuels the growth of the aquaculture vaccines market.

North America Aquaculture Vaccines Market Overview

The North America aquaculture vaccines market is segmented into the US, Canada, and Mexico. The market growth in this region is attributed due to the growing aquaculture industry and surging demand for aquatic animal-derived food products. The US aquaculture vaccines market holds a significant share in North America. The market growth is due to increasing aquaculture production, high prevalence of infectious diseases in the aquaculture sector, and rising development and launch of new aquaculture vaccines. According to The OECD Review of Fisheries 2020, in 2018, the US produced 5.2 million tonnes of fish, valued at US$ 7063.5 million. 83% from fisheries, and 17% of this value came from aquaculture. Between 2008 and 2018, the production quantity increased by 7%, while its value raised by 29%. Further, In July 2020, Zoetis acquired Fish Vet Group from Benchmark Holdings, PLC, as a strategic addition to its Pharma business which develops and commercializes fish vaccines and offers services in vaccination and diagnostics for aquaculture. Adding Fish Vet Group grows the geographic reach and improves the diagnostics expertise and testing services, including environmental testing, that Pharmaq's reference lab Pharmaq Analytiq can now offer fish farmers in major aquaculture markets. Thus, the growing developments by various market players in the US aquaculture industry, along with the aforementioned factors, will boost the market for aquaculture vaccines in the US.

North America Aquaculture Vaccines Market Revenue and Forecast to 2028 (US$ Million)

North America Aquaculture Vaccines Market Segmentation

The North America aquaculture vaccines market is segmented into type of vaccine, species, route of administration, and country.

Based on type of vaccine the North America aquaculture vaccines market, is segmented into live vaccines, inactivated vaccines, other vaccines. The inactivated vaccines segment held the largest market share in in 2022.

Based on species, the North America aquaculture vaccines market is divided into tilapia, trout, salmon, shrimps, and others. The salmon segment held the largest share of the market in 2022.

Based on route of administration the North America aquaculture vaccines market, is segmented into injection vaccines, immersions vaccines, and oral vaccines. The injection vaccines segment held the largest share of the market in 2022.

Based on country, the North America aquaculture vaccines market is segmented into the US, Canada, and Mexico. The US dominated the aquaculture vaccines market share in 2022.

AquaTactics Fish Health; HIPRA SA; Merck & Co Inc.; Zoetis Inc.; Phibro Animal Health Corp; and Elanco Animal Health Inc. are the leading companies operating in the North America aquaculture vaccines market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America aquaculture vaccines market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America aquaculture vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the aquaculture vaccines market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Aquaculture Vaccines Market - by Type of Vaccine
    • 1.3.2 North America Aquaculture Vaccines Market - by Species
    • 1.3.3 North America Aquaculture Vaccines Market - by Route of Administration
    • 1.3.4 North America Aquaculture Vaccines Market - by Country

2. North America Aquaculture Vaccines Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Aquaculture Vaccines Market - Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Expert's Opinion

5. North America Aquaculture Vaccines Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Aquaculture Industry
    • 5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
  • 5.2 Market Restraints
    • 5.2.1 Strict Regulatory Policies for Approval of Vaccines and High Cost of Vaccines
  • 5.3 Future Trends
    • 5.3.1 Development of Novel Vaccines
  • 5.4 Impact Analysis

6. Aquaculture Vaccines Market - North America Analysis

  • 6.1 North America Aquaculture Vaccines Market Revenue Forecast & Analysis

7. North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 - by Type of Vaccine

  • 7.1 Overview
  • 7.2 North America Aquaculture Vaccines Market Revenue Share, by Type of Vaccine 2021 & 2028 (%)
  • 7.3 Live Vaccines
    • 7.3.1 Overview
    • 7.3.2 Live Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Inactivated Vaccines
    • 7.4.1 Overview
    • 7.4.2 Inactivated Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Other Vaccines
    • 7.5.1 Overview
    • 7.5.2 Other Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Aquaculture Vaccines Market Analysis and Forecasts to 2028 - by Species

  • 8.1 Overview
  • 8.2 North America Aquaculture Vaccines Market, by Species 2021 & 2028 (%)
  • 8.3 Tilapia
    • 8.3.1 Overview
    • 8.3.2 Tilapia: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Trout
    • 8.4.1 Overview
    • 8.4.2 Trout: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Salmon
    • 8.5.1 Overview
    • 8.5.2 Salmon: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Shrimps
    • 8.7.1 Overview
    • 8.7.2 Shrimps: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 - by Route of Administration

  • 9.1 Overview
  • 9.2 North America Aquaculture Vaccines Market Revenue Share, by Route of Administration 2021 & 2028 (%)
  • 9.3 Injection Vaccines
    • 9.3.1 Overview
    • 9.3.2 Injection Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Immersions Vaccines
    • 9.4.1 Overview
    • 9.4.2 Immersions Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Oral Vaccines
    • 9.5.1 Overview
    • 9.5.2 Oral Vaccines: North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Aquaculture Vaccines Market - Revenue and Forecast to 2028 - Country Analysis

  • 10.1 North America: Aquaculture Vaccines Market
    • 10.1.1 Overview
      • 10.1.1.1 US: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 US: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.1.4 US: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.1.5 US: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.2 Canada: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Canada: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Canada: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Canada: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)
      • 10.1.1.3 Mexico: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico: Aquaculture Vaccines Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 Mexico: Aquaculture Vaccines Market, by Type of Vaccine, 2019-2028 (US$ Million)
        • 10.1.1.3.4 Mexico: Aquaculture Vaccines Market, by Species, 2019-2028 (US$ Million)
        • 10.1.1.3.5 Mexico: Aquaculture Vaccines Market, by Route of Administration, 2019-2028 (US$ Million)

11. Aquaculture Vaccines Market - Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Aquaculture Vaccines Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 AquaTactics Fish Health
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 HIPRA SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Merck & Co Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Zoetis Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Phibro Animal Health Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Elanco Animal Health Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms